Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: TRACERx

Study suggests tumour microenvironments could predict cancer progression

NSCLC is the most common type of lung cancer and is responsible for up to 85% of all […]

April 12, 2024 Bristol Myers Squibb, Cancer Research UK, Francis Crick Institute, lung cancer, News, non-small cell lung cancer, Oncology, TRACERx, University College London
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy